Failure of anti-TNF therapy in TNF receptor 1 - Associated Periodic Syndrome (TRAPS) [5]

Rheumatology

Volumn 46, Issue 7, 2007, Pages 1211-1212

  Jacobelli, S ^a   Andre M ^b   Alexandra, J F ^a   Dode C ^c   Papo, Thomas ^b  

^a BICHAT HOSPITAL   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c Cochin Hospital ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; ETANERCEPT; INFLIXIMAB; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; STEROID; TUMOR NECROSIS FACTOR ANTIBODY;

ABDOMINAL PAIN; ADULT; ANEMIA; ARM EDEMA; CASE REPORT; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHEMA; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HUMAN; LETTER; LIMB SWELLING; LOW DRUG DOSE; MYOSITIS; PRIORITY JOURNAL; RECURRENT DISEASE; SELF MEDICATION; SHORT COURSE THERAPY; SPASTICITY; THORAX PAIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FAMILIAL MEDITERRANEAN FEVER; HUMANS; IMMUNOGLOBULIN G; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TREATMENT FAILURE;

EID: 34447308222     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel298     Document Type: Letter

References (10)

1. Touitou I, Lesage S, McDermott M et al. Infevers: An evolving mutation database for auto-inflammatory syndromes. Hum Mutat 2004;24:194-8.
2. Dodé C, Papo T, Fieschi C et al. A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family. Arthritis Rheum 2000;43:1535-42.
3. Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumor necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): Clinical and laboratory findings in a series of seven patients. Rheumatology 2003;42:235-9.
4. Drewe E, Powell RJ. Novel treatments for tumor necrosis factor receptor-associated periodic syndrome (TRAPS): Case history of experience with infliximab and sirolimus post etanercept. Clin Exp Rheum 2002;4:S71.
5. Hull KM, Aksentijevich I, Singh H, Dean J, Yarboro C, O'Shea JJ, Kastner DL. Efficacy of etanercept for the treatment of patients with TNF receptor-associated periodic syndrome (TRAPS). Arthritis Rheum 2003;48(Suppl.)S378- Abstract 977.
6. Weyhreter H, Schwartz M, Kristensen TD, Velerius NH, Paerregaard A. A new mutation causing autosomal dominant periodic fever syndrome in a Danish family. J Padiatr 2003;142:191-3.
7. Arostagui JI, Solis P, Aldea A et al. Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response. Eur J Pediatr 2005;164:13-6.
8. Hentgen V, Reinert P. TNF receptor-associated periodic syndrome (TRAPS): clinical aspects and physiopathology of a rare hereditary periodic fever syndrome. Arch Pediatr 2003;10:45-53.
9. Drewe E, Lanyon PC, Powell RJ. Emerging clinical spectrum of tumor necrosis factor receptor-associated periodic syndrome: Comment on the articles by Hull et al and Dode et al. Arthritis Rheum 2003;48:1769-70.
10. Nowlan ML, Drewe E, Bulsara H et al. Systemic cytokine levels and the effects of etanercept in TNFreceptor-associated periodic syndrome (TRAPS) involving a C33Y mutation inTNFRSF1A. Rheumatology 2006;45:31-7.